AzTrials
AzTrials

Country

Clinical Trials in Zambia

Studies with at least one site in Zambia. Open a trial for its sites in Zambia, who to contact and who can take part.

354 registered studies

In numbers

Open to volunteers
39
Active
57
With results posted
48
All registered
354

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 39
  • Violence by Teachers

    School-based Prevention of Teacher Violence Against Children in Zambia

    • Recruiting
    • Age: 8 to 80 years
    • Lifestyle or therapy programme

    The United Nations Conventions on the Rights of the Child UN General Assembly, 1989), outlawed violence against children worldwide.

    Trial name
    ICC-T Zambia (NCT07773961)
    Testing
    Interaction Competencies with Children
    Where
    Zambia
    Volunteers
    700 people, healthy volunteers welcome
    Sponsor
    Tobias Hecker, PhD
  • Hepatitis B, HIV

    Integrating Hepatitis B Elimination Into the HIV Program in Zambia

    • Enrolling by invitation
    • Age: 18 years and older
    • Vaccines

    The goal of this study is to develop an integrated HBV-HIV service care model in Zambia by working with people living with HBV, healthcare workers, policy makers and other key stakeholders to co-design an intervention.

    Conditions
    Hepatitis B, HIV, Implementation Science
    Trial name
    INTEGRATE B (NCT07875218)
    Testing
    Integrated HBV/HIV Service Delivery Model
    Where
    Zambia
    Volunteers
    460 people, healthy volunteers welcome
    Sponsor
    Centre for Infectious Disease Research in Zambia
    Can I take part? INTEGRATE B
  • Long COVID

    Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

    • Recruiting
    • Age: 18 to 65 years
    • Phase 3
    • Pill or oral medicine

    The Long-Covid (LC)-Revitalize clinical study is testing repurposed drug treatments for Long Covid, involving adult participants from Brazil, Canada, Italy, South Africa, Uganda, the United States, and Zambia.

    Trial name
    NCT06928272
    Testing
    Pirfenidone, Upadacitinib
    Where
    10 sites in United States, Brazil and 5 more
    Volunteers
    348 people
    Sponsor
    Douglas D. Fraser
  • Cholera Vaccination Reaction

    Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers

    • Recruiting
    • Age: 18 to 55 years
    • Phase 1
    • Vaccines
    • Pill or oral medicine

    Cholera is a serious diarrheal disease that can be fatal within hours of onset. The current available cholera vaccines to prevent the disease are not very effective.

    Trial name
    PanChol (NCT07107516)
    Testing
    PanChol
    Where
    Zambia
    Volunteers
    32 people, healthy volunteers welcome
    Sponsor
    Centre for Infectious Disease Research in Zambia
    Can I take part? PanChol
  • Fetal Weight, Pregnancy

    Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

    • Recruiting
    • Age: 18 years and older

    Purpose: The primary objective of this study is to assess the diagnostic accuracy of an AI-enabled ultrasound tool for estimating fetal weight Participants: 1,000 pregnant individuals Procedures (methods): This prospective…

    Conditions
    Fetal Weight, Pregnancy, Machine Learning, Pregnancy - Prenatal Testing
    Trial name
    krittenhouse (NCT07661433)
    Testing
    AI ultrasound diagnostic tool for fetal weight estimation
    Where
    6 sites in United States, Canada and 2 more
    Volunteers
    1,000 people
    Sponsor
    University of North Carolina, Chapel Hill
  • Feasibility Study, Vaccine Immune Response

    How Gut Health Affects Immune Responses to the Oral Rotavirus Vaccine in Adults in Zambia

    • Recruiting
    • Age: 18 to 50 years
    • Observational study
    • Vaccines
    • Pill or oral medicine

    The Rotavirus SpatioTrasncriptomics (Rota-Omics) study is a multidisciplinary research project aimed at understanding why oral rotavirus vaccines perform less effectively in some low- and middle-income countries, including…

    Conditions
    Feasibility Study, Vaccine Immune Response, Rota Virus Gastroenteritis, Transcriptomics
    Trial name
    Rota-Omics (NCT07626606)
    Testing
    Rotarix®,
    Where
    Zambia
    Volunteers
    43 people, healthy volunteers welcome
    Sponsor
    Centre for Infectious Disease Research in Zambia
    Can I take part? Rota-Omics
  • Tuberculosis, Multidrug-Resistant

    Bioneer Q-RFIA Clinical Evaluation

    • Recruiting
    • Age: 18 years and older
    • Observational study

    Robust evidence on the clinical diagnostic accuracy and operational characteristics of the Bioneer Accupower Q-RFIA PCR kit on IRON qPCR is required to comprehensively evaluate validity of the Bioneer RFIA assay to support both…

    Trial name
    NCT05117788
    Testing
    Estimate the diagnostic accuracy of the Bioneer Accupower Q-RFIA PCR kit on IRON qPCR for MTB detection using culture as reference standard. Estimate the diagnostic accuracy of the Bioneer Ac
    Where
    5 sites in Kenya, Moldova and 3 more
    Volunteers
    2,350 people
    Sponsor
    Foundation for Innovative New Diagnostics, Switzerland
    Can I take part? NCT05117788
  • HIV, Syphilis

    Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study

    • Not yet recruiting
    • Age: 18 years and older

    The goal of this clinical trial is to find out if sex work managers (also called "queen mothers") can help female sex workers (FSW) get tested for HIV and other sexually transmitted infections (STIs) by giving out and collecting…

    Conditions
    HIV, Syphilis, Gonorrhea, Chlamydia
    Trial name
    PHASES (NCT07829133)
    Testing
    Venue-based, peer-enhanced strategy for integrated HIV self-testing (and self-collected STI testing
    Where
    Zambia
    Volunteers
    232 people, healthy volunteers welcome
    Sponsor
    University of North Carolina, Chapel Hill
    Can I take part? PHASES
  • Low Birth Weight, Kangaroo Mother Care

    Admission to Kangaroo Mother Care (KMC) Ward and Maternal Postpartum Depression

    • Recruiting
    • Age: 1 day to 89 years
    • Lifestyle or therapy programme

    The goal of this clinical trial is to learn if extended admission to the Kangaroo Mother Care (KMC) ward helps to prevent postpartum depression in mothers of low birthweight infants in a low-resource setting whose newborns were…

    Conditions
    Low Birth Weight, Kangaroo Mother Care, Postpartum Depression, Neurodevelopmental Outcome
    Trial name
    KMC PPD (NCT06545760)
    Testing
    Kangaroo mother care (KMC) support for > 2 days, Kangaroo mother care (KMC) support for < 2 days
    Where
    Zambia
    Volunteers
    1,908 people
    Sponsor
    University of Alabama at Birmingham
    Can I take part? KMC PPD
  • Severe Malaria, Thrombocytopenia

    Platelet-Directed Whole Blood Transfusion Strategy for Malaria

    • Recruiting
    • Age: 1 month to 59 months

    Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.

    Trial name
    PLATFORM (NCT05711485)
    Testing
    Whole blood transfusion
    Where
    2 sites in United States, Zambia
    Volunteers
    132 people
    Sponsor
    Johns Hopkins Bloomberg School of Public Health
    Can I take part? PLATFORM

Completed, with results posted

All –
  • Alcohol and Substance-Related Mental Disorders

    Effectiveness of an Evidence-based Stepped Care System for Alcohol and Other Drug Use Problems Among Congolese Refugees in Zambia

    • Completed
    • Age: 15 years and older
    • Lifestyle or therapy programme
    • Results posted

    This is a randomized controlled trial (RCT) evaluating the effectiveness of a screening, brief intervention, and referral to treatment (SBIRT) stepped-care system in reducing unhealthy AOD use among Congolese refugees and the…

    Trial name
    NCT05471921
    Testing
    SBIRT, Treatment as usual
    Where
    2 sites in United States, Zambia
    Volunteers
    400 people
    Sponsor
    Columbia University
    Can I take part? NCT05471921
  • Stroke

    Zambia Stroke Unit Study

    • Completed
    • Age: 18 years and older
    • Results posted

    The goal of this clinical trial is to evaluate the impact of a locally adapted stroke unit on outcomes of adults with stroke in Zambia.

    Trial name
    ZASUS (NCT06457048)
    Testing
    Stroke Unit
    Where
    Zambia
    Volunteers
    300 people
    Sponsor
    Johns Hopkins University
    Can I take part? ZASUS
  • Human Immunodeficiency Virus, HBV

    Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

    • Completed
    • Age: 18 years and older
    • Observational study
    • Results posted

    A cohort of adults with HIV-HBV co-infection will be created in Lusaka, Zambia, to describe the short and long-term (up to 10 years of follow-up) HBV and liver outcomes, including the effectiveness of current therapies, and to…

    Conditions
    Human Immunodeficiency Virus, HBV, Fibrosis, Liver, Cirrhosis, Liver
    Trial name
    NCT02344680
    Testing
    Anti-HIV Agents
    Where
    Zambia
    Volunteers
    349 people
    Sponsor
    University of Alabama at Birmingham
  • HIV Infections, Pregnancy Related

    Happy Homes, Healthy Families: A Relationship Strengthening Intervention for Pregnant Couples Affected by HIV in Zambia

    • Completed
    • Age: 18 years and older
    • Lifestyle or therapy programme
    • Results posted

    The objective of this study is to test the preliminary efficacy of a novel couples' counseling intervention to promote the health of pregnant women living with HIV in Lusaka, Zambia.

    Trial name
    NCT04729413
    Testing
    Couples Counseling, Enhanced Standard of Care
    Where
    Zambia
    Volunteers
    478 people
    Sponsor
    University of Colorado, Denver
    Can I take part? NCT04729413
  • SARS-CoV-2 Infection, HIV Infections

    Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

    • Completed
    • Age: 18 years and older
    • Phase 2/3
    • Vaccines
    • Injection or infusion
    • Results posted

    The study will evaluate the clinical efficacy of different dosing regimens of the Moderna COVID-19 mRNA vaccine (100 mcg) in preventing COVID-19 disease in people who are living with HIV or have comorbidities associated with…

    Conditions
    SARS-CoV-2 Infection, HIV Infections, COVID-19
    Trial name
    CoVPN3008 (NCT05168813)
    Testing
    Moderna mRNA-1273, Moderna mRNA-1273.222, Vaccine 3 Dose
    Where
    47 sites in Botswana, Eswatini and 5 more
    Volunteers
    14,237 people
    Sponsor
    COVID-19 Prevention Network
    Can I take part? CoVPN3008

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in